PI3Kα targeting, nipping pancreatic cancer evolution in the bud

EMBO Mol Med. 2021 Jul 7;13(7):e14362. doi: 10.15252/emmm.202114362. Epub 2021 May 31.

Abstract

Thibault et al (2021) elucidate key signalling events mediating metastatic evolution in pancreatic ductal adenocarcinoma (PDAC) by demonstrating a role of PI3Kα in the regulation of macro-metastatic disease and a corresponding pro-tumoural immune response supporting disease progression.

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Carcinoma, Pancreatic Ductal* / genetics
  • Humans
  • Pancreatic Neoplasms* / genetics